
Malaria vaccine shows promise against relapsing form of the disease
12 July 2023
A vaccine induced an immune response against the malaria parasite Plasmodium vivax, which can remain dormant in the body and cause a relapse of symptoms

12 July 2023
A vaccine induced an immune response against the malaria parasite Plasmodium vivax, which can remain dormant in the body and cause a relapse of symptoms

10 July 2023
A gene-editing technique makes mosquitoes produce antibodies against the malaria parasite, which could mean cases in people are also slashed

27 June 2023
Five malaria cases have been reported in Florida and Texas, all of which were acquired through local transmission

13 April 2023
A malaria vaccine that is 77 per cent effective in clinical trials has been approved for use in children 3 to 5 years old, the group most vulnerable to dying from the disease

21 September 2022
Gene editing mosquitoes so they die before malaria parasites can develop inside them could stop the spread of the deadly parasite entirely, according to lab studies and computer models

21 September 2022
After being bitten by malaria-carrying mosquitoes, people with a certain mix of gut bacteria had much higher levels of the parasite in their blood than those with different microbes

20 September 2022
A fungal skin disease that caused amphibian numbers to plummet in Costa Rica and Panama lowered the number of amphibian tadpoles that were eating mosquito larvae, allowing the insects to flourish and spread malaria

16 May 2022
Detailed analysis of mosquito bites in the Central African Republic found that, contrary to assumptions, many occur indoors during the daytime when people are not well protected by traditional anti-malaria defences

17 February 2022
Experiments show that two species of mosquitoes change their behaviour after exposure to five common pesticides, which could make the chemicals less effective

7 October 2021
The WHO has approved the first vaccine against malaria in the world, for use in children in sub-Saharan Africa